Pancreatic Cancer: Antiplatelet Therapy Study

We are investigating if adding an antiplatelet medication to standard care can help prevent blood clots in patients with pancreatic cancer. We also want to see if it may improve survival rates.

6-12 months 6-10 visits Confirmation phase (III)No Placebo Partially Remote Standard Medicines Oral InjectionCardiologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Fragmin

Fragmin is a medicine that helps prevent and treat blood clots by thinning the blood.

Plavix

Plavix is a medicine that helps prevent harmful blood clots and lowers the risk of heart attack and stroke.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Clopidogrel

Clopidogrel is a substance that helps prevent blood clots by stopping platelets from sticking together, lowering the risk of heart attack and stroke.

Dalteparin Sodium

Dalteparin sodium is a blood thinner used to prevent and treat harmful blood clots.

Fondaparinux Sodium

Fondaparinux sodium is a substance used to prevent and treat blood clots by reducing the blood's ability to form clots.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Aclop

Adagrel

Agrelan

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Nordlandssykehuset HF

Department of Cancer

Bodø, Norway

Drammen Sykehus

Department of Oncology

Drammen, Norway

Sykehuset Oestfold HF Kalnes

Oncology

Sarpsborg, Norway

Sponsor: Akershus University Hospital

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.